Filters
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Ashkenazi Jewish Breast Cancer Test Fulgent Genetics United States | 10 | 2 |
|
Fulgent Genetics United States | 180 | 60 |
|
ACMG Secondary Findings (Medically Actionable Genes, Including Cardio and Cancer) NGS Panel Fulgent Genetics United States | 177 | 59 |
|
Comprehensive Primary Immunodeficiency NGS Panel Fulgent Genetics United States | 1048 | 472 |
|
Breast and Ovarian Cancer Focus Panel Fulgent Genetics United States | 50 | 21 |
|
Fulgent Genetics United States | 34 | 9 |
|
Breast and Ovarian Cancer Comprehensive Panel Fulgent Genetics United States | 58 | 24 |
|
Fulgent Genetics United States | 82 | 30 |
|
Prostate Cancer Comprehensive Panel Fulgent Genetics United States | 29 | 12 |
|
Ovarian Cancer Comprehensive Panel Fulgent Genetics United States | 39 | 18 |
|
Endometrial Cancer Comprehensive Panel Fulgent Genetics United States | 33 | 10 |
|
Breast Cancer Comprehensive Panel Fulgent Genetics United States | 52 | 20 |
|
Full Comprehensive Cancer Panel Fulgent Genetics United States | 329 | 127 |
|
Pancreatic Cancer Comprehensive Panel Fulgent Genetics United States | 55 | 22 |
|
Fulgent Genetics United States | 55 | 13 |
|
Fulgent Genetics United States | 29 | 12 |
|
Fulgent Genetics United States | 33 | 15 |
|
Endometrial Cancer Focus Panel Fulgent Genetics United States | 33 | 10 |
|
Fulgent Genetics United States | 40 | 14 |
|
Fulgent Genetics United States | 8 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.